Subscribe 600$/product give away!
Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

ACZONE 7.5- dapsone gel

Patient Information

Advise the patient to read the FDA-approved patient labeling (Patient Information).

Hematological Effects

  • Inform patients that methemoglobinemia can occur with topical dapsone treatment. Advise patients to seek immediate medical attention if they develop cyanosis[see Warnings and Precautions (5.1)].
  • Inform patients who have G6PD deficiency that hemolytic anemia may occur with topical dapsone treatment. Advise patients to seek medical attention if they develop signs and symptoms suggestive of hemolytic anemia[see Warnings and Precautions (5.1)].

Important Administration Instructions

  • Advise patients to applyACZONEGel, 7.5%, once daily to the entire face[see Dosage and Administration (2)].
  • ACZONEGel, 7.5% is for topical use only.
  • Do not applyACZONEGel, 7.5% to eyes, mouth, or mucous membranes.

Distributed by: Allergan USA, Inc.
Madison, NJ 07940

2018 Allergan. All rights reserved.
All trademarks are the property of their respective owners.
Patented. See:



-------Cut Herecut----------------------------------------------------------------------------------------------------------------

Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: